Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

A small regulatory element from chromosome 19 enhances liver-specific gene expression.

Li C, Hirsch M, Carter P, Asokan A, Zhou X, Wu Z, Samulski RJ.

Gene Ther. 2009 Jan;16(1):43-51. doi: 10.1038/gt.2008.134.

3.
5.

Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.

Recchia A, Perani L, Sartori D, Olgiati C, Mavilio F.

Mol Ther. 2004 Oct;10(4):660-70.

6.

Characterization of a bipartite recombinant adeno-associated viral vector for site-specific integration.

Zhang C, Cortez NG, Berns KI.

Hum Gene Ther. 2007 Sep;18(9):787-97.

PMID:
17760515
7.

Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.

Müller OJ, Leuchs B, Pleger ST, Grimm D, Franz WM, Katus HA, Kleinschmidt JA.

Cardiovasc Res. 2006 Apr 1;70(1):70-8.

PMID:
16448634
8.

Optimization of recombinant adeno-associated viral vectors for human beta-globin gene transfer and transgene expression.

Maina N, Zhong L, Li X, Zhao W, Han Z, Bischof D, Aslanidi G, Zolotukhin S, Weigel-Van Aken KA, Rivers AE, Slayton WB, Yoder MC, Srivastava A.

Hum Gene Ther. 2008 Apr;19(4):365-75. doi: 10.1089/hum.2007.173.

PMID:
18399730
9.

Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors.

Gray SJ, Foti SB, Schwartz JW, Bachaboina L, Taylor-Blake B, Coleman J, Ehlers MD, Zylka MJ, McCown TJ, Samulski RJ.

Hum Gene Ther. 2011 Sep;22(9):1143-53. doi: 10.1089/hum.2010.245.

10.

Optimization of transcriptional regulatory elements for constructing plasmid vectors.

Xu ZL, Mizuguchi H, Ishii-Watabe A, Uchida E, Mayumi T, Hayakawa T.

Gene. 2001 Jul 11;272(1-2):149-56.

PMID:
11470520
11.

Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.

Hermonat PL, Santin AD, De Greve J, De Rijcke M, Bishop BM, Han L, Mane M, Kokorina N.

J Hum Virol. 1999 Nov-Dec;2(6):359-68.

PMID:
10774553
12.

Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.

Fraefel C, Jacoby DR, Lage C, Hilderbrand H, Chou JY, Alt FW, Breakefield XO, Majzoub JA.

Mol Med. 1997 Dec;3(12):813-25.

13.

Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element.

Wang L, Wang Z, Zhang F, Zhu R, Bi J, Wu J, Zhang H, Wu H, Kong W, Yu B, Yu X.

Int J Med Sci. 2016 Apr 1;13(4):286-91. doi: 10.7150/ijms.14152.

14.

Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.

Wang CY, Guo HY, Lim TM, Ng YK, Neo HP, Hwang PY, Yee WC, Wang S.

J Gene Med. 2005 Jul;7(7):945-55.

PMID:
15756650
15.

Gene therapy for hemophilia B with liver-specific element mediated by Rep-RBE site-specific integration system.

Xu Z, Ye J, Zhang A, Xie L, Shen Q, Xue J, Chen J.

J Cardiovasc Pharmacol. 2015 Feb;65(2):153-9. doi: 10.1097/FJC.0000000000000172.

PMID:
25295466
16.

Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.

Oehmig A, Cortés ML, Perry KF, Sena-Esteves M, Fraefel C, Breakefield XO.

Gene Ther. 2007 Jul;14(14):1078-91.

PMID:
17460718
17.

Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers.

Yan Z, Sun X, Feng Z, Li G, Fisher JT, Stewart ZA, Engelhardt JF.

Hum Gene Ther. 2015 Jun;26(6):334-46. doi: 10.1089/hum.2015.001.

18.

Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator.

Mori-Uchino M, Takeuchi T, Murakami I, Yano T, Yasugi T, Taketani Y, Nakagawa K, Kanda T.

J Gene Med. 2009 Jul;11(7):598-604. doi: 10.1002/jgm.1337.

PMID:
19399759
19.

Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors.

Hauser MA, Robinson A, Hartigan-O'Connor D, Williams-Gregory DA, Buskin JN, Apone S, Kirk CJ, Hardy S, Hauschka SD, Chamberlain JS.

Mol Ther. 2000 Jul;2(1):16-25.

20.

Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.

Jayandharan GR, Zhong L, Sack BK, Rivers AE, Li M, Li B, Herzog RW, Srivastava A.

Hum Gene Ther. 2010 Mar;21(3):271-83. doi: 10.1089/hum.2009.100.

Supplemental Content

Support Center